"The Institute for Reproductive Health is a multidisciplinary group practice specializing in the complete care of the infertile patient. We offer diagnostic work-ups as well as all the full range of therapeutic options. We are a full-service fertility center, providing basic and advanced infertility therapy, such as: In Vitro Fertilization (IVF) ICSI Donor Egg Tubal Reversal Vasectomy Reversal Surrogacy Sperm Banking Egg Freezing PGS We serve clients from Cincinnati, Northern Kentucky, Dayton, Indiana, Lexington and Louisville. We have offices in Cincinnati and Kentucky."

During the past decade, Institute for Reproductive Health conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute for Reproductive Health" #1 sponsor was "Ferring Pharmaceuticals" with 5 trials, followed by "Femasys Inc." with 1 trials sponsored, "Fertility Biotech AG" with 1 trials sponsored, "Forest Laboratories" with 1 trials sponsored and "Nora Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Institute for Reproductive Health" are "Infertility" (7 trials), "Infertility, Female" (1 trials), "Male Factor" (1 trials), "Primary Amenorrhea With Hypogonadotropic Hypogonadism" (1 trials) and "Repeated IVF Failure" (1 trials). Many other conditions were trialed in "Institute for Reproductive Health" in a lesser frequency.

Most popular intervention types in "Institute for Reproductive Health" are "Drug" (7 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Follitropin delta" (2 trials), "AFOLIA" (1 trials), "Diafert" (1 trials) and "FemaSeed Localized Directional Insemination" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Reproductive Health" are 10 trials for "Female" genders.

Currently, there are NaN active trials in "Institute for Reproductive Health". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Institute for Reproductive Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Reproductive Health, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".